Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000902664-24-006448
Filing Date
2024-11-13
Accepted
2024-11-13 09:00:21
Documents
1

Document Format Files

Seq Description Document Type Size
1 ADAPTIVE BIOTECHNOLOGIES CORPORATION p24-3149sc13ga.htm SC 13G/A 57896
  Complete submission text file 0000902664-24-006448.txt   59733
Mailing Address 1000 WINTER STREET C/O MATRIX CAPITAL MANAGEMENT WALTHAM MA 02451
Business Address 1000 WINTER STREET C/O MATRIX CAPITAL MANAGEMENT WALTHAM MA 02451 781-522-4948
Matrix Capital Management Company, LP (Filed by) CIK: 0001410830 (see all company filings)

EIN.: 043475951 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 1165 EASTLAKE AVE E SEATTLE WA 98109
Business Address 1165 EASTLAKE AVE E SEATTLE WA 98109 206-659-0067
Adaptive Biotechnologies Corp (Subject) CIK: 0001478320 (see all company filings)

EIN.: 270907024 | State of Incorp.: WA | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-91363 | Film No.: 241451430
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)